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The protozoan parasite Trypanosoma cruzi is the causative agent of human Chagas disease, for which there currently is no cure.
T h el i f ec y c l eo fT. cruzi is complex, including an extracellular phase in the triatomine insect vector and an obligatory intracellular
stage inside the vertebrate host. These phases depend on a variety of surface glycosylphosphatidylinositol-(GPI-) anchored
glycoconjugates that are synthesized by the parasite. Therefore, the surface expression of GPI-anchored components and the
biosynthetic pathwaysof GPI anchorsare attractive targets fornew therapies forChagasdisease. Weidentiﬁed new drug targets for
chemotherapy by takingthe availablegenomesequence informationand searching for diﬀerences in the sphingolipid biosynthetic
pathways (SBPs) of mammals and T. cruzi. In this paper, we discuss the major steps of the SBP in mammals, yeast and T. cruzi,
focusing on the IPC synthase and ceramide remodeling of T. cruzi as potential therapeutic targets for Chagas disease.
1.Introduction
Sphingolipids(SLs)belongtoadiversegroupofamphipathic
lipids that have essential functions in eukaryotes. They are
constituentsofcellularmembranecompartmentsandpartic-
ipateinadiversearray ofsignaltransductionprocesses[1,2].
The ﬁnal products of the sphingolipid biosynthetic pathways
(SBPs) are diﬀerentin mammals, fungi, plants and protozoa.
Thus, certain steps of this pathway are potential targets for
chemotherapy against fungal [3] and protozoal infections
[4–6]. Sphingomyelin (SM) is the primary phosphosphin-
golipid that is produced by mammalian cells, including in
humans [7]. This molecule is formed by the transfer of the
choline-phosphate head group from phosphatidylcholine
(PC) to ceramide, a reaction catalyzed by SM synthase [8].
In contrast, plants, fungi, and some protozoa synthesize
inositolphosphorylceramide (IPC) as their primary phos-
phosphingolipid [9]. In this pathway, the IPC synthase
enzyme [10] catalyzes the transfer of inositol phosphate
to ceramide. IPC makes up a relatively low proportion of
fungal phospholipids. Nonetheless, it is essential, as IPC
synthase-null mutants are not viable [11]a n di n h i b i t o r so f
this enzyme kill fungal cells [12, 13].
Numerousproteins and glycolipidsare attached to mem-
branes by a glycosylphosphatidylinositol (GPI) anchor. This
posttranslational modiﬁcation is conserved among yeast,
protozoa, plants and animals [14]. All of these groups except
animals have GPI anchors containing IPC as an attached
lipid.GPIbiosynthesisisessentialformammalian embryonic
development and the growth of yeasts and trypanosomes
[15–17]. The biosynthesis and maturation of GPI anchors
occurs during the ER-to-Golgi transit, beginning with
the sequential addition of sugars and ethanolamine phos-
phates to phosphatidylinositol (PI). Subsequent structural
remodeling reactions can happen during biosynthesis or
after attachment to proteins. Most of these steps have been
studied at the biochemical and molecular levels [18, 19].
Recently, it has been shown that GPI lipid remodeling
reactions are important for maintaining the correct fate
of GPI-anchored glycoconjugates and their proper associ-
ation with microdomains in certain cellular processes [20,
21].2 Enzyme Research
Several neglected tropical diseases worldwide are caused
by a group of trypanosomatid protozoan parasites (also
known as Tritryps), including the following: (i) African try-
panosomes (Trypanosoma brucei subspecies), which cause
sleeping sickness, (ii) multiple Leishmania species, which
cause cutaneous and visceral forms of leishmaniases, and
(iii) Trypanosoma cruzi, which causes Chagas disease [22–
26]. Recent studies have shown that all of these parasites are
capable of synthesizing IPC and that the expression of IPC is
regulated during development.
The genome sequences of these pathogenic microrgan-
isms have recently been published, allowing us to search for
diﬀerences between the SL and GPI structures of mammals
and Tritryps to identify novel drug targets. Here, we will
discuss the major steps of the SBP in mammals, yeast and
Tritryps. We will focus on the IPC synthase and ceramide
remodeling of T. cruzi as potential therapeutic targets for
Chagas disease.
2.InitialStepsinthe De Novo Synthesisof
a SphingoidLong-ChainBase
In all eukaryotes, de novo SL biosynthesis starts with the con-
densation of L-serine and palmitoyl-CoA into 3-ketodi-hy-
drosphingosine (3-KDS), as shown in Figure 1 and Table 1.
Ap y r i d o x a l5  -phosphate-dependent enzyme called serine
palmitoyltransferase (SPT) catalyzes this reaction. The SPT
enzyme (Figure 1 and Table 1,S t e p1 )i sac o m p l e xo ft w o
subunits, SPT1 and SPT2 [27]. In yeast, the small peptide
TSC3 signiﬁcantly enhances SPT activity [28]. Two open
reading frames (ORFs) with homology to yeast LCB1 and
LCB2 canbefoundintheTritrypgenomedatabase.Although
SPT1p and SPT2p function as a heterodimer, all experimen-
tal data indicate that the SPT2 subunit contains the catalytic
site [28]. For this reason, most of the studies on Tritryps
(mainly L. major and T. brucei) have focused on SPT2.
TheexpressionoftheLmSPT2gene(alsocalledLmLCB2)
is developmentally regulated. LmSPT2p is undetectable
in the late stationary growth phase of promastigotes, as
well as in metacyclic trypomastigotes and intramacrophage
amastigotes [29, 30]. Deletion of the SPT2 gene in L. major
resultsin a completelossofIPC and ceramide,whereas other
alkyl/acyl and acyl/acyl phospholipids remain unchanged
[29]. Although spt2
− mutant promastigotes are viable and
grow during log phase, they fail to eﬃciently diﬀerentiate
into infective metacyclic trypomastigotes and die rapidly
at this stage. This phenotype can be rescued either by the
addition of sphingoid bases (3-ketodihydrosphinsosine or 3-
KDS, dihydrosphingosine, sphingosine, and phytosphingo-
sine),ethanolamine (EtN)orEtN-phosphate to the medium,
or by complementation with the original LmLCB2 gene
[29–33]. However, neither ceramide nor SM can rescue the
stationary phasedefectsorrestoreIPCsynthesis [29].Similar
observations have previously been made in yeast and mam-
malian SPT-deﬁcient mutants [34, 35]. Denny and Smith
[30] showed that exocytic traﬃcking is compromised in
spt2
− mutants, but Zhang and colleagues [29, 32]o b s e r v e d
little negative eﬀect on vesicular traﬃcking. However, both
groups found that spt2
− parasites retain their ability to form
membrane microdomains and lipid rafts [29, 32, 33]. It
has been suggested that Leishmania can compensate for the
loss of SLs by increasing its overall level of lipid synthesis,
for example, by increasing ergosterol [31]o rG I P L[ 33]
production. These spt2− mutants are still able to establish
infection in a mouse model, although with some delay
[33], conﬁrming that the ﬁrst step in the de novo SBPs is
unnecessary for either the survival of Leishmania within host
macrophages or the resulting pathogenesis.
In contrast, the ﬁrst step of the SBPs, which is catalyzed
by SPT, is essential in T. brucei.T h i sc o n c l u s i o nw a sb a s e do n
pharmacological experiments with myriocin (Figure 1,S t e p
1), an inhibitor of SPT [36], and genetic experiments [37,
38]. These perturbations most profoundly aﬀect viability,
cellular proliferation and cytokinesis, with marginal eﬀects
onsecretorytraﬃckingandlipidraftformation.SLdepletion
can be rescued by the addition of 3-KDS, the immediate
downstream intermediate in the SBPs, but not by the
addition of ceramide or EtN [37, 38]. These results indicate
that T. brucei absolutely requires de novo synthesis of SLs.
In the second step of SL biosynthesis (Figure 1 and
Table 1, Step 2), the product 3-KDS is rapidly converted
into dihydrosphingosine (DHS; sphinganine) in a NADPH-
dependent manner by the 3-ketodihydrosphingosine reduc-
tase (KDSR) encoded by TSC10 (temperaturesensitive sup-
pressor ofcgs2Δ)inS.cerevisiae [39]andb yFV T -1(follicular
lymphoma variant translocation-1) in mammals [40].
Although KDSR activity has not been measured in parasites,
TSC10 homologues can be found in the genomes of Tritryps
(Table 1). A predicted TcKDRS can be found in the GeneDB
database in two genomic fragments (Tc00.1047053510997.10
and Tc00.1047053506959.64)w h o s en u c l e o t i d ea n da m i n o
acidsequencesare 98%identical.These probablycorrespond
to the two haplotypes present in the hybrid CL-Brener strain
[41].
3.CeramideSynthase:
The CentralAxisof theSBPs
The next step in the SBPs, the synthesis of ceramide,
is a key component of the pathway (Figure 1 and Table 1,
Step 3). Ceramide is critical for cell growth and functions
in several diﬀerent cellular events, including apoptosis,
growth arrest, endocytosis and stress responses [42–44].
Ceramide can be degraded by a ceramidase, or the sphingoid
bases can be phosphorylated to produce DHS-1-P/SPH-1-
P signaling molecules (Figure 1). Ceramide is synthesized
mainly from the reaction of a fatty acyl-CoA with a
sphingoid base catalyzed by an acyl-CoA:sphingosine N-
acyltransferase or ceramide synthase (CerS) [45, 46]. An
acyl-CoA-independent CerS activity has been described [47,
48] although it probably represents a reversal of ceramidase
action. In yeasts, the long-chain base (LCB) DHS can
be hydroxylated at C-4 by SUR2/SYR2 [49]t of o r mt h e
sphingoid base phytosphingosine, which is later N-acylated
by either of the two CerSs, encoded by LAG1 (longevity
assurance gene) or LAC1 [50, 51], to yield phytoceramide.Enzyme Research 3
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Figure 1: General scheme of the SBP in Tritryps. Substrates, products, enzymes and eﬀective/potential (?) inhibitors of the four (1–4) initial
SBP steps are indicated as described in the text and in Table 1.
In mammals, DHS can be directly N-acylated by a family of
CerSs encoded by CERS1-6 genes [52]. In addition, another
essential component of the yeast CerS, known as Lip1p,
was described recently. It forms a heteromeric complex with
Lac1p and Lag1p and is required for CerS activity in yeast
[53]. No orthologue ofLip1 has yet been found in nonfungal
species.
In Trypanosomatids, ceramide can be found as a lipid
component of phospholipids like SM, in T. brucei, and IPC,
which is expressed in all Tritryps [54–62]. CerS activity has
beenidentiﬁed[54]andcharacterizedatthebiochemicaland
molecular levels only in T. cruzi ([63], submitted). The
TcCerS was initially identiﬁed by the incorporation of
[3H]palmitic acid into ceramides, which were chemically
degraded to radiolabeled dihydrosphingosine and fatty acid
[54]. More recently, TcCerS activity has been detected
in a cell-free system using the microsomal fraction of
epimastigoteformsofT. cruzi.Inthissystem,theenzymewas
shown toemploybothsphingoidlong-chain bases (DHSand
SPH) ([63], submitted). This activity requires acyl-CoAs,4 Enzyme Research
Table 1:Genesrequired forsphingolipidbiosynthesisandlipidremodelingstepsinmammals,Saccharomycescerevisiae, Trypanosomabrucei,
Leishmania major,a n dTrypanosoma cruzi.
Step Activity Mammals S. cerevisiae T. brucei L. major T. cruzi
1S P TLCB1
LCB2
LCB1/LCB2
TSC3
TbSPT1
TbSPT2
LmSPT1
LmSPT2
TcSPT1
TcSPT2
2K D S RFVT-1 TSC10 Tb927.10.4040(a) LmjF.35.0330 Tc00.1047053510997.10
Tc00.1047053506959.64(a)
3C E R S CERS1-6 LAG1/LAC1
LIP1
Tb927.8.7730
Tb927.4.4740 LmjF.31.1780 TcCERS1
4S L SSMS1
SMS2
AUR1
KEI1 TbSLS1-4 LmIPCS TcIPCS1
TcIPCS2
5I D PGAP1 BST1 GPIdeAc2 —(b) Tc00.1047053508153.1040(a)
6 GPIPLA2 PGAP3 PER1 —— —
7L G P I A T - I PGAP2 GUP1 TbGUP1
LmjF.19.1000/LmjF.19.1320
LmjF.19.1340/LmjF.19.1345
LmjF.19.1347(a)
TcGUP1(c)
8C R — CWH43 — LmjF27.1770(a) Tc00.1047053504153.120(a)
(a)Corresponding homologues of each yeast gene were found by BLAST at NCBI and GeneDB (http://www.genedb.org/).
(b)Not found.
(c)TcGUP can be Tc00.1047053508943.4, Tc00.1047053511355.59,o rTc00.1047053503809.90.
with palmitoyl-CoA being preferred. In addition, Fumonisin
B1, a broadly active and well-known acyl-CoA-dependent
CerS inhibitor (Figure 1, Step 3), blocks parasite CerS
activity ([63], submitted). However, unlike what has been
observed in fungi, the CerS inhibitors Australifungin [64]
and Fumonisin B1 [65]d on o ta ﬀect the proliferation of
epimastigotes in culture ([63], submitted). Orthologues of
the conserved Lag1-domain from yeast CerS, LAG1,w e r e
identiﬁed in a search of the Tritryp genome sequences
(Table 1). The T. cruzi candidate gene (TcCERS1), which
was hypothesized to encode the parasite’s CerS orthologue,
can functionally complement the lethality of a lag1Δ lac1Δ
double-deletion yeast mutant that has no detectable acyl-
CoA-dependent CerS ([63], submitted).
Glycoinositolphospholipids (GIPLs) are abundant sur-
faceglycoconjugatesofT. cruzi andareinvolvedin thepatho-
genesis of Chagas disease [66, 67]. GIPLs contain an IPC-
lipid anchor that is formed by dihydroceramide N-acylated
with palmitic or lignoceric acids [68–72]. TcCerS uses only
palmitoyl-CoA as a substrate donor ([63], submitted); it
is not known how the parasite incorporates C24:0 into
ceramides. Recently, a novel fatty acid synthesis system was
identiﬁed in the Tritryps [73]. In this system, synthesis is
mediated by elongases that prime a butyryl-CoA molecule
with malonyl-CoA units as the donor substrate and promote
fatty acid extension to a length of 18 carbons or longer.
Therefore, it is possible that this system elongates shorter
fattyacidstoC24:0sothattheycanthenbeincorporatedinto
ceramides. Alternatively, the substrate could be another fatty
acid, like arachidonate (C20:4 from extracellular sources),
whichcouldbeelongatedand desaturatedfurthertogenerate
very-long-chain fatty acids [73]. Finally, IPC acyl-hydrolase
and IPC acyl-transferase activities have been detected in
membranes of T. cruzi [74, 75]a n dc o u l db ei n v o l v e di nt h e
remodeling of the endogenous ceramide C16:0 fatty acids by
an extracellular fatty acid (see below).
4.IPC Synthase Activity
The synthesis of IPC (Figure 1 and Table 1,S t e p4 A )o c c u r s
by the transfer of inositol phosphate from PI to the C-1
hydroxyl group of ceramide or phytoceramide. This reaction
is catalyzed by IPC synthase, which is localized to the Golgi
ofyeasts. IPCsynthase isencodedbyAUR1 (alsocalledIPC1)
[11]. As already mentioned, IPC represents a relatively low
proportion of fungal phospholipids, but it is essential. IPC
synthase-null mutants are not viable [11], and fungal cells
are killed by the IPC synthase inhibitors Aureobasidin A
(AbA) [12]a n dR u s t m i c i n[ 13]. Recently, a critical protein
interaction partner for yeast IPC synthase was identiﬁed and
named Kei1p. It was shown that Kei1p is essential for both
yeast IPC synthase activity and for its sensitivity to AbA [76].
As shown in Figure 1 (Step 4B), mammals cannot synthesize
IPC;instead, theyproduceSMusingtwomajorSMsynthases
[8]e n c o d e db ySM1 and SM2 (Table 1,S t e p4 ) .
In yeasts, IPC is found as a lipid in complex SLs [9]o r
in mature GPI-anchored surface proteins. It is composed of
a sphingoid-base with N-acylated C18:0–C26:0 fatty acids
[18,77,78].InT. cruzi,IPCis found in themajority of GIPLs
(in epimastigotes) [67–70], the GPI anchors of Ssp4 antigen
(in amastigotes) [54], trans-sialidase and Tc-85 glycoprotein
(in trypomastigotes) [79, 80], mucins and 1G7-Ag (in
metacyclic forms) [71, 81, 82]. In replacement of IPC, GPI-
anchoredproteinscontainonly1-O-hexadecylglycerol-based
PIs [71, 72, 81–84]. The lipid moiety of GIPLs also includes
a small amount (2–8%) of 1-O-hexadecyl-2-acyl-PIs [72,
85]. Thus, there is a developmentally regulated expression
[54] and distribution of ceramide in T. cruzi GPI-anchored
components. In T. brucei bloodstream forms, GPI-protein
anchors contain dimyristoylglycerol, whereas in Leishmania,
t h e s ea n c h o r sa r em a i n l yc o m p o s e do fsn-1-alkyl-2-acyl-PI
or sn-1-alkyl-2-lyso-PI [14]. In Leishmania, IPC is present
together with other SLs and sterols in organized lipid raftsEnzyme Research 5
[86] but it is never found attached to any GPI-anchored
protein or GIPL [14]. In T. brucei, IPC has been found
in insect-stage procyclic forms (PCFs), but its role remains
unclear [38, 60, 87].
Another SL that is producedby T. brucei is SM. This lipid
hasbeendetectedusingacombinationofmethods,including
metabolic labeling, enzyme treatments and high-resolution
mass spectrometry, in both insect and mammalian stages
of the parasite [61, 88]. The relative amount of SM in PCF
cells is signiﬁcantly lower than that in blood-stream forms
(BSFs)[87],probablybecausetheceramideinBSFsisusedin
conjunction with PC to form SM, whereas in PCFs ceramide
is also used to form IPC from PI [38, 61]. In BSF parasites
of T. brucei, the unusual phosphosphingolipid ethanolamine
phosphorylceramide (EPC, Figure 1, Step 4C) was detected
for the ﬁrst time by Sutterwala and colleagues [61]. Its
presence was later conﬁrmed by a lipidomic analysis [87].
The IPC synthases of L. major (LmIPCS)a n dT. cruzi
(TcIPC1 and TcIPC2) and the SL synthase (SLS) family
of T. brucei (TbSLS1-4) were initially identiﬁed in the
GeneDBdatabasebasedonsequencesimilarity [4].These are
shown in Table 1 (Step 4). The TbSLS genes are organized
in a unique linear tandem array. All Tritryp sequences
are predicted to have six trans-membrane (TM) domains
and two luminal motifs that likely constitute the catalytic
domain. Each Tritryp sequence contains histidine and aspar-
tate residues that mediate nucleophilic attack on the lipid
phosphate ester bonds. This predicted topology more closely
resembles that of mammalian SMSs, which also have the
signature motifs (D1-4),than thefungal IPCsynthase, which
contains only the D3-4 motifs and is encoded by AUR1/KEI1
genes [4, 8, 11, 61, 62].
All the TbSLSs genes are constitutively expressed in
both stages of the life-cycle (PCF and BSF). Simultaneous
knockdown of the four TbSLS genes using a pan-speciﬁc
RNAi showed that the TbSLS gene products are required for
cell viability [61]. The activity of each of the TbSLS gene
products has been validated with genetic and biochemical
analyses, as well as with a recently developed cell-free
system for the synthesis of active polytopic membrane
proteins. TbSLS1p is an IPC synthase and is expressed in
PCFs, whereas TbSLS2p is an EPC synthase, and TbSLS3p
and TbSLS4p are bifunctional SM/EPC synthases [61, 62].
Sequence alignments and site-speciﬁc mutagenesis indicate
that the speciﬁc phospholipid head group donor depends on
subtle diﬀerences in active site residues [62]. Taken together,
the existing data support the ability of T. brucei to synthesize
IPC (Figure 1,S t e p4 A ) ,S M( Figure 1,S t e p4 B )a n dE P C
(Figure 1,S t e p4 C ) .
The Lederkremer’s group was the ﬁrst to identify IPC
in T. cruzi epimastigotes [57], trypomastigotes [58]a n d
amastigotes[54,75].IPCsynthase activitywasinitiallyfound
in the microsomal membranes of all life-cycle stages of T.
cruzi [59]. The TcIPC synthase activity is consistent with
the proposed reaction scheme for IPC synthase in fungi
and plants, though there are diﬀerences in the optimal pH
conditions, metal requirements and detergent preferences
[59]. The classical inhibitors of fungal IPC synthase, rust-
micin and AbA, do not inhibit T. cruzi IPC synthase in
vitro (over the range of 0.9–7μM) and do not aﬀect the
proliferation of epimastigotes in culture(>40μM). However,
AbA inhibits both the proliferation of amastigotes inside
macrophages and the release of trypomastigotes from these
cells in a dose-dependent manner [59]. The reduction in
intracellular proliferation can be partially attributed to the
eﬀect of this drug on macrophage function, diminishing
phagocytic capacity and nitric oxide production [59].
Similar results have been obtained with AbA in T. brucei
SL synthesis [62], suggesting that the IPC synthase enzyme is
not the main target of AbA in parasites. Nonetheless, TbSLSs
remain potential chemotherapeutic targets, as T. brucei is
critically dependent on de novo synthesis of sphingolipids
to survive. Mass spectrometry of lipids extracted from AbA-
treated L. major promastigotes has shown that there is no
eﬀect on IPC synthesis, unless very high concentrations of
AbA are administered (>5.0μM) [29].
5.The LipidRemodelingReactions
More than 20 genes involved in GPI biosynthesis and protein
attachment have been identiﬁed. In most cases, these genes
are conserved from yeast to mammalian cells [18, 89]. As
in mammals, yeasts, T. brucei and Leishmania, the ﬁrst steps
of GPI anchor biosynthesis in T. cruzi do not include a
ceramide precursor [90, 91]. Thus, ceramide is probably
added during a later remodeling step in T. cruzi [75, 90, 91],
as in yeasts [78, 92, 93]. Although there are diﬀerences in
theceramidecomposition, remodeling inyeast happensafter
the attachment of the GPI anchor to the proteins, whereas in
T. cruzi, remodeling may occur on the GPI protein anchors
and/or GIPLs.
Lipid remodeling of GPI-anchored proteins has been
studied in fungi, mammals and T. brucei [20, 21]. The four
most important enzymes and the genes involved in this
process are listed in Table 1 (Steps 5–8); the lipid remodeling
reactions are depicted in a simpliﬁed scheme in Figure 2.
In mammals, the ﬁrst reaction is a deacylation to remove
the fatty acid linked to position C-2 of the GPI anchor
inositol ring (Table 1 and Figure 2, Step 5). This reaction is
c a t a l y z e db yP G A P 1 p( p o s t G PI attachment to protein 1) and
occurs before the GPI-attached proteins leave the ER, as it
is critical for eﬃcient transit of GPI anchored proteins to
the Golgi [94]. The second reaction is the removal of the
unsaturated acyl chain from the sn-2 position of the alkyl-
acyl-glycerolipid to form a lyso-GPI (Table 1 and Figure 2,
Step 6). This reaction is catalyzed by PGAP3p [95]. The ﬁnal
reaction in mammals is the transfer of a saturated acyl chain
(C18:0) to the sn-2 position of the lyso-GPI species (Table 1
and Figure 2, Step 7). PGAP2p is one protein involved in
this process [96], but it is probably not an acyl-transferase
because it has no homology to acyltransferases [21].
Mature GPI-anchored proteins in yeasts contain two dif-
ferent types of lipid moieties [77, 78, 92]. The ﬁrst is a
diacylglycerol with a C26:0 fatty acid at the sn-2 position.
The second is a ceramide containing mainly C18:0 phy-
tosphingosine and a C26:0 fatty acid [78]. In both cases, the
C26:0 fatty acid may be 2-hydroxylated. As mentioned above6 Enzyme Research
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fumigatus (ASPFU), Emericella nidulans (EMENI), Saccharomyces cerevisiae (YEAST) and Schizosaccharomyces pombe (SCHPO) were
compared with the putative CWH43p candidates from Leishmania major (LEIMA), Leishmania infantum (LEIIN) and Trypanosoma cruzi
(TRYCR). Thick horizontal bars indicate the relative positions of the membrane-spanning domains as predicted by the TMHMM Server.
Dashed lines delineate the relative positions of the FRAG1 and DNase I-like domains, which are located at the N- and C-terminus,
respectively.
for mammals, lipid remodeling of the yeast GPI-anchored
proteins starts in the ER with the removal of the fatty acid
linked to the C-2 position of the GPI anchor inositol ring
(Table 1 and Figure 2, Step 5). This reaction is catalyzed
by the PGAP1p orthologue BST1p [94]. Unlike mammals,
which have a sn-1-alkyl-2-acyl-glycerolipid attached to the
GPI, yeasts have a diacyl-glycerolipid (Figure 2). The next
step is the removal of the C18:1 fatty acid at the sn-2
position of diacylglycerol to form a lyso-GPI (Figure 2,S t e p
6). This reaction is performed by GPI phospholipase A2
(GPI-PLA2), which requires PER1p (Table 1,S t e p6 )f o r
its activity [94, 95]. Next, the free sn-2 position is ﬁlled
with a C26:0 fatty acid (Figure 2,S t e p7 )b ya na c y l -
transferase called GUP1p [97]. Finally, the diacylglycerol
lipid moiety is replaced by a ceramide (Figure 2,S t e p8 )
with C18:0 phytosphingosine and a hydroxy-C26:0 fatty acid
[78]. It has been reported recently that CWH43p (Table 1,
Step 8) is responsible for this replacement [98, 99]. Indeed,
the exchange reaction requires the C-terminus of CWH43p,
and the association of the CWH43p-N with the CWH43p-C
enhances the lipid remodeling reaction [99]. The alignment
of CWH43p to its homologues in ﬁssion yeast (Shizosac-
charomyces pombe), ﬁlamentous fungi, mice and humans
has identiﬁed conserved residues that are important for
the lipid remodeling function, including H802, D862 and
R882, and protein stability (G57) [97, 99]. The N-terminal
region of yeast CWH43 has a FRAG1 domain (Figure 3),
which is also present in PGAP2p and is thought to act as
a protein interaction motif that enhances stability under
conditions of replicative stress [21]. The C-terminal region
of CWH43 also has a DNase I-like motif (Figure 3)t h a ti s
found in Isc1p, Inp51p, Inp52p, Inp53p and Inp54p. Isc1p is
an inositol phosphosphingolipid phospholipase C [20], and
the Inp51/52/53/54 proteins are phosphoinositol phos-
phatases [21]. This motif may be involved in the recognition
of inositol phosphate, in which case the DNase I-like region
i nt h eC - t e r m i n a ld o m a i no fC W H 4 3 pc o u l db ei m p o r t a n t
for the recognition of PI on the GPI anchor.
The sequential remodeling reactions mentioned above
comprise one of the three possible pathways for lipid remod-
eling in yeast (Figure 2, compare full with dashed lines).
Another may be a divergent pathway, in which the lyso-GPI
generated by PER1p is a direct substrate for the ceramide
remodeling activity of CWH43p [99]. CWH43p could be
involved in the direct exchange of glycerolipids containing
an unsaturated fatty acid for the ceramide moiety. This third
alternative is proposed to function as a backup if the ﬁrst
one, which is mediated by PER1p and GUP1p, is defective
[94, 98, 99].
Acyl exchange also occurs in T. brucei, but in this organ-
ism, the remodeling happens before (during GPI anchor
biosynthesis) and after the GPI anchor precursor is trans-
ferred onto the protein[100].T. brucei contains two diﬀerent
GPI deacylation/reacylation pathways. One pathway (termed
lipid remodeling) acts onlipid A
  (a GPI anchor biosynthetic
precursor containing a sn-2-heterogenous fatty acid) to
generate lipid A (containing sn-1, 2-dimyristoylglycerol),
creatingtheintermediateslipidθ (lyso-GPI)andlipidA
   (sn-
1-stearoyl-2-myristoylglycerol). The other pathway (termed
lipid exchange) acts on both GPI proteins and lipid A
and exchanges the original myristate for another myristate
[100, 101]. The acyl transferase GUP1p has homologues
encoded in the genomes of T. brucei and T. cruzi (Table 1,
Step 7). In T. brucei, TbGUP1p is required for the acylation
of lipid θ (lyso-PI) to generate lipid A
   (sn-1-stearoyl-2-
myristoylglycerol) intheremodelingofGPIlipids[100,101].8 Enzyme Research
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Figure 4: Alignment of the amino acid sequences of CWH43p homologues. Amino acid sequences of Aspergillus fumigatus
(Q4WXJ6 ASPFU), Emericella nidulans (Q5B369 EMENI), Saccharomyces cerevisiae (CWH43 YEAST) and Schizosaccharomyces pombe
(CWH43 SCHPO) proteins were aligned with the sequences of putative CWH43p candidates in Leishmania major (Q4FYE4 LEIMA),
Leishmania infantum (A4I2W7 LEIIN) and Trypanosoma cruzi (Q4B2S1 TRYCR) using ClustalW.Identical amino acids are in reverse type,
and conserved residues are shaded accordingly. The FRAG1 domain is shown in (a) the DNase I-like domain is shown in (b) Asterisks (∗)
indicate the relative positions of amino acid residues that are essential for ceramide remodeling catalysis.TM, transmembrane stretches.
Although the remodeling of GPI anchors is important in
several species to ﬁrmly anchor GPI proteins onto lipid
bilayersand directthemtothecorrectcellularcompartments
and membrane domains [95], GPI lipid remodeling is not
important for the stability and surface expression of the
essential variant surface glycoprotein (VSG) [101]. The lack
of GPI remodeling could be compensated in vivo by the
myristate exchange pathway [100].
Like TbGUP1p, the T. cruzi GUP1p (Table 1,S t e p7 )c a n
reacylate lyso-GPI anchors (Figure 2, Step 7), indicating that
a similar pathway mediated by GUP1p is present in both
yeasts and protozoa [97, 101]. Although several putativeEnzyme Research 9
GUP1 orthologues have been found in Leishmania (Table 1,
Step7), thereis no experimental evidencefor theexistence of
this kind of lipid remodeling in these parasites. Additionally,
IPChasnotbeenf oundt obelink edt oGPIanc hor sorGIPLs
[14]. Therefore, targeted deletion studies in Leishmania
could be used to determine the participation and function
of these SBPs genes [29].
In T. cruzi, lipid remodeling occurs most likely as depict-
ed in Figure 2. Unlike what has been described for mammals
and yeasts, in this organism, the GPI anchor precursor
molecule that is attached to the proteins is not acylated
at position C-2 of the inositol ring [90]. Nonetheless, a
putative TbGPIdeAc orthologue can be found in the T. cruzi
genome database (Table 1,S t e p5 ) .I nT. cruzi,i n t e r m e d i a t e
GPI anchor precursors combine acylated and nonacylated
inositol, as in T. brucei [90]. Thus, the putative orthologue
(Tc00.1047053508153.1040) could be involved in deacylation
during GPI biosynthesis. Although they are not acylated at
the inositol ring, the GPI anchor precursors (either before
or after attachment to proteins) contain a sn-1-alkyl-2-acyl-
glycerolipid moiety [90]( Figure 2). However, Lederkremer’s
group has also detected a GPI-anchor precursor in T. cruzi
that contains a mono-acyl-glycerol moiety [91]. There are
no orthologues for the mammalian PGAP3p or yeast PER1p
in the Tritryp genomes (Table 1, Step 6). It has been shown
that T. cruzi lysates contain a PLA2 activity that uses PI as a
substrate [74], but it is not known whether this activity can
also act on GPI-containing substrates. As mentioned above,
TcGUP1p (Figure 2 and Table 1, Step 7) can reacylate lyso-
GPI substrates [99, 101] ,b u ti ti sn o tc l e a rw h i c ho ft h e
putative homologues encoded in the genome was used in
those studies (Table 1,S t e p7 ) .
A putative orthologue of yeast CWH43p has been iden-
tiﬁed in the genomes of T. cruzi (Tc00.1047053504153.120),
L. major (LmjF27.1770)( Table 1,S t e p8 )a n dL. infantum
(LinJ27 V3.1670). This protein could have the ceramide
remodeling activity that is supposed to exchange the sn-1-
alkyl-2-acyl-glycerolipid of the GPI for a ceramide moiety
in T. cruzi (Figure 2, Step 8 continuous or dashed lines).
As already mentioned, no information is available on the
function of these putative orthologues in Leishmania since
ceramide is not found in their GPI anchors.
To learn more about the CWH43p orthologues in Trit-
ryps, a multiple sequence alignment was prepared to com-
pare these sequences with “bonaﬁde” fungal CWH43p se-
quences. The results are presented in Figures 3 and 4.A s
shown in Figure 3, the Tritryp orthologues contain as many
T Md o m a i n sa st h ef u n g a lC W H 4 3 ps e q u e n c e s .H o w e v e r ,
these domains have a greater distribution along the length
of the sequences of T. cruzi and Leishmania. In addition,
all the sequences have a highly conserved FRAG1 domain
at the N-terminus and a DNase I-like domain at the C-
terminus (Figure 3). A closer view of each of these conserved
d o m a i n si ss h o w ni nFigure 4. The FRAG1 domain has a
high degree of identity across all sequences. The conserved
residue G59 (G57 in yeast), which is essential for catalysis
[99, 101], is located between the ﬁrst and second TM
domains (Figure 4(a), “∗”). A high degree of identity is also
apparent in the DNase I-like domain at the C-terminus.
The catalytically important residue H1076 (H802 in yeast)
is conserved across all sequences (Figure 4(b), “∗”). Taken
together, these data indicate that T. cruzi encodes a putative
ceramide remodeling enzyme, which is essential in fungi and
has no homologues in mammals.
6.ConcludingRemarks
In T. cruzi, GPI-anchored glycoconjugates such as mucins,
trans-sialidases, gp82/90glycoproteinsandGIPLsmayexten-
sivelycoattheplasmamembraneoftheparasite.Theseglyco-
conjugates are involved in many aspects of the host-parasite
interaction,suchasadhesionandinvasion ofhostcells,mod-
ulation and evasion from the host immune response, and
pathogenesis [66, 67, 83]. In addition, the GPI anchors, or
certain parts of them, seem to act as strong proinﬂammatory
molecules during the immune response against this parasite
[66]. Therefore, mechanisms that interfere with the surface
expression of GPI-anchored proteins and GIPLs or with the
biosynthesis of GPI anchors are very attractive targets for
new therapiesagainst Chagasdisease. Here, we discussed two
novel targets in the SBPs of T. cruzi:t h eI P Cs y n t h a s ea n d
ceramide remodeling. Because fungicidal inhibitors of IPC
synthase activity do not aﬀect the trypanosomal enzyme, the
identiﬁcation of novel inhibitors of this enzyme should be a
goal of future research. This research direction could require
the development of novel HTPS methods, such as the plate-
based assay for screening Leishmania IPC synthase inhibitors
that was recently developed by Mina and colleagues [102].
Unfortunately, recombinant parasite IPC synthase is pre-
pared by overexpression in a fungal heterologous system,
which has completely diﬀerent optimal enzyme conditions
and extra cofactors that would aﬀect inhibition by novel
candidates. Biochemical enzymatic assays have not been
developed for ceramide remodeling, but recent advances
have been made in monitoring the in vitro incorporation of
ceramides into GPI-anchored proteins in S. cerevisiae [103].
These methods could be developed for use in T. cruzi.
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